BEDU-ADDO FRANK 4
4 · PDS Biotechnology Corp · Filed Dec 2, 2022
Insider Transaction Report
Form 4
BEDU-ADDO FRANK
DirectorPresident/CEO
Transactions
- Exercise/Conversion
Common Stock
2022-12-02$6.57/sh+219,535$1,442,345→ 866,050 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-12-02−219,535→ 0 totalExercise: $6.57Exp: 2022-12-03→ Common Stock (219,535 underlying) - Tax Payment
Common Stock
2022-12-02$9.78/sh−175,184$1,713,300→ 690,866 total
Footnotes (2)
- [F1]This stock option was fully vested in accordance with its terms.
- [F2]On December 2, 2022, Dr. Bedu-Addo made a net exercise of 219,535 stock options, resulting in his acquisition of 44,351 common shares of the Issuer.